{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:42:43Z","timestamp":1773283363442,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.07.017","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T09:48:04Z","timestamp":1354960084000},"page":"G18-G24","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S6","title":["Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study"],"prefix":"10.1016","volume":"30","author":[{"given":"F.","family":"Charfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Smaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kechrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.07.017_bib0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7883\/yoken.JJID.2006.299","article-title":"Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococcal isolates in Asturias, Spain","volume":"59","author":"Garc\u00eda-Su\u00e1rez","year":"2006","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.arcped.2006.11.012","article-title":"Mortalit\u00e9 par m\u00e9ningites \u00e0 pneumocoque chez l\u2019enfant. Facteurs pronostiques \u00e0 propos d\u2019une s\u00e9rie de 73 observations","volume":"14","author":"Thabet","year":"2007","journal-title":"Arch Pediatr"},{"issue":"Suppl. S1","key":"10.1016\/j.vaccine.2012.07.017_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/dkf808","article-title":"Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study and comparative in vitro activity of the ketolide, telithromycin","volume":"50","author":"Felmingham","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2012.07.017_bib0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.arcped.2008.12.015","article-title":"Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolates in children in Tunis","volume":"16","author":"Smaoui","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0030","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2012.07.017_bib0035","first-page":"253","article-title":"Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine \u2013 United States, 2007","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0040","unstructured":"Soussy CJ. Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Recommandations; 2009."},{"key":"10.1016\/j.vaccine.2012.07.017_bib0045","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization \u2013 WHO position paper","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0050","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3346\/jkms.2010.25.6.895","article-title":"The causative organisms of bacterial meningitis in Korean children in 1996\u20132005","volume":"25","author":"Cho","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0399-077X(01)00306-7","article-title":"Profil bact\u00e9riologique des m\u00e9ningites purulentes \u00e0 l\u2019H\u00f4pital d\u2019Enfants de Tunis","volume":"32","author":"Thabet","year":"2002","journal-title":"M\u00e9d Mal Infect"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.medmal.2009.03.006","article-title":"Actualisation de l\u2019\u00e9pid\u00e9miologie des m\u00e9ningites bact\u00e9riennes de l\u2019enfant en France","volume":"39","author":"Levy","year":"2009","journal-title":"M\u00e9d Mal Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2012.07.017_bib0065","first-page":"331","article-title":"Streptococcus pneumoniae of lesser sensitivity to penicillin in the Sfax region, Tunisia (1994\u20131995)","volume":"46","author":"Feki-Berrajah","year":"1998","journal-title":"Pathol Biol (Paris)"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.07.017_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2009.02724.x","article-title":"The antimicrobial resistance profile of Streptococcus pneumoniae","volume":"15","author":"Reinert","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/AAC.45.2.627-629.2001","article-title":"Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities","volume":"45","author":"Benbachir","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/46.5.767","article-title":"Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and \u03b2-lactam consumption in Spain (1979\u20131997)","volume":"46","author":"Granizo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0085","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/432721","article-title":"Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae","volume":"41","author":"Guillemot","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0090","unstructured":"Varon E, Gutmann L. Rapport d\u2019activit\u00e9s du Centre National de R\u00e9f\u00e9rence des Pneumocoques; 2005."},{"key":"10.1016\/j.vaccine.2012.07.017_bib0095","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0369-8114(02)00322-X","article-title":"Place du pneumococque en pathologie infectieuse p\u00e9diatrique","volume":"50","author":"Bingen","year":"2002","journal-title":"Path Biol"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dkh469","article-title":"Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14","volume":"54","author":"Dias","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jinf.2007.12.002","article-title":"Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and micribiological case series from 1992 to 2006","volume":"56","author":"Montagnani","year":"2008","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2012.07.017_bib0110","first-page":"87","article-title":"Study of the sensitivity to antibiotics and genes for macrolide resistance to Streptococcus pneumoniae isolated in a pediatric Tunisian setting","volume":"5","author":"Smaoui","year":"2011","journal-title":"Revue Tunisienne d\u2019Infectiologie"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.patbio.2007.05.005","article-title":"Phenotypic and genotypic characterization of macrolide resistant S. pneumoniae in Tunisia","volume":"56","author":"Rachdi","year":"2008","journal-title":"Pathol Biol (Paris)"},{"issue":"7","key":"10.1016\/j.vaccine.2012.07.017_bib0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10096-007-0321-5","article-title":"Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae","volume":"26","author":"Riedel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.07.017_bib0125","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijantimicag.2009.03.022","article-title":"New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992\u20132008)","volume":"34","author":"Im\u00f6hl","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.vaccine.2012.07.017_bib0135","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1469-0691.2008.02058.x","article-title":"Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5years and under in Saudi Arabia (2000\u20132004)","volume":"14","author":"Shibl","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2012.07.017_bib0140","doi-asserted-by":"crossref","first-page":"e10000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Peumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.07.017_bib0145","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1128\/AAC.01268-09","article-title":"Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates","volume":"54","author":"Xu","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.vaccine.2012.07.017_bib0150","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24months: a meta-analysis","volume":"23","author":"Pavia","year":"2009","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2012.07.017_bib0155","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pneumococcal serotypes in children in 4 European countries","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.017_bib0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":"The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12010195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12010195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T01:55:10Z","timestamp":1714701310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12010195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":32,"alternative-id":["S0264410X12010195"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}